Drug portfolio prioritization
MedImmune is a Washington DC-area biotechnology firm, headquartered in Gaithersburg, MD. Best known for their child respiratory and flu vaccines, the company was acquired in 2007 by pharmaceutical giant AstraZeneca PLC. MedImmune is now the global biologics unit for AstraZeneca, with approximately 3,500 employees worldwide. They are using Decision Lens for drug portfolio and related prioritzed decision-making.